Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Iradimed (IRMD) Revenue (2016 - 2026)

Iradimed has reported Revenue over the past 14 years, most recently at $22.0 million for Q1 2026.

  • Quarterly Revenue rose 12.65% to $22.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $86.3 million through Mar 2026, up 14.81% year-over-year, with the annual reading at $83.8 million for FY2025, 14.43% up from the prior year.
  • Revenue was $22.0 million for Q1 2026 at Iradimed, down from $22.7 million in the prior quarter.
  • Over five years, Revenue peaked at $22.7 million in Q4 2025 and troughed at $12.3 million in Q1 2022.
  • The 5-year median for Revenue is $17.6 million (2024), against an average of $17.5 million.
  • Year-over-year, Revenue skyrocketed 33.46% in 2022 and then increased 10.87% in 2025.
  • A 5-year view of Revenue shows it stood at $14.9 million in 2022, then rose by 17.42% to $17.5 million in 2023, then rose by 11.1% to $19.4 million in 2024, then grew by 17.03% to $22.7 million in 2025, then fell by 3.14% to $22.0 million in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Revenue are $22.0 million (Q1 2026), $22.7 million (Q4 2025), and $21.2 million (Q3 2025).